- Home
- EOG vs BSX Comparison
EOG vs BSX Comparison
Compare EOG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EOG | BSX |
|---|---|---|
| Founded | 1985 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.6B | 68.0B |
| IPO Year | 2006 | 2010 |
Fundamental Metrics
Financial Performance| Metric | EOG | BSX |
|---|---|---|
| Price | $158.14 | $44.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 33 | 31 |
| Target Price | ★ $168.00 | $49.60 |
| AVG Volume (30 Days) | 3.1M | ★ 18.6M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | ★ 14.18 | 1.92 |
| Revenue | ★ $22,632,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $42.43 | $4.46 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $10.99 | $23.05 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $101.59 | $39.57 |
| 52 Week High | $165.93 | $102.71 |
Technical Indicators
Market Signals| Indicator | EOG | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 50.35 |
| Support Level | $135.47 | $41.92 |
| Resistance Level | $165.93 | $46.31 |
| Average True Range (ATR) | 4.18 | 1.77 |
| MACD | -0.43 | 0.08 |
| Stochastic Oscillator | 64.25 | 63.99 |
Price Performance
Historical ComparisonAbout EOG EOG Resources Inc.
EOG Resources is an oil and gas producer with acreage in several US shale plays, primarily in the Permian Basin and the Eagle Ford. At the end of 2024, it reported net proven reserves of 4.7 billion barrels of oil equivalent. Net production averaged roughly 1,232 thousand barrels of oil equivalent per day in 2025 at a ratio of 69% oil and natural gas liquids and 31% natural gas.
About BSX Boston Scientific Corporation
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.